Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

(±) -Equol (Standard)

(±) -Equol (Standard) is the analytical standard of (±) -Equol. This product is intended for research and analytical applications. (±) -Equol is the racemate of equol. (±) -equol exhibits EC50s of 200 and 74 nM for human ERα and ERβ, respectively. Equol is a metabolite of the soy isoflavones, daidzin and daidzein.

Product Specifications

CAS Number

94105-90-5

UNSPSC

12352005

Target

Drug Metabolite; Estrogen Receptor/ERR; Reference Standards

Related Pathways

Metabolic Enzyme/Protease; Others; Vitamin D Related/Nuclear Receptor

Field of Research

Cancer; Neurological Disease; Cardiovascular Disease

Smiles

OC1=CC=C2CC(C3=CC=C(O)C=C3)COC2=C1

Molecular Formula

C15H14O3

Molecular Weight

242.27

References & Citations

[1]Axelson M, et al. The identification of the weak oestrogen equol [7-hydroxy-3- (4'-hydroxyphenyl) chroman] in human urine. Biochem J. 1982 Feb 1;201 (2) :353-7.|[2]Setchell KD, et al. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr. 2005 May;81 (5) :1072-9. human intestinal bacterial flora.|[3]Wang J, et al. Equol promotes rat osteoblast proliferation and differentiation through activating estrogen receptor. Genet Mol Res. 2014 Jul 4;13 (3) :5055-63.|[4]Gimenez I, et al. Renal and vascular actions of equol in the rat. J Hypertens. 1997 Nov;15 (11) :1303-8.|[5]Choi EJ, et al. Anticancer mechanism of equol in 7,12-dimethylbenz (a) anthracene-treated animals. Int J Oncol. 2011 Sep;39 (3) :747-54.|[6]Charoenthongtrakul S, et al. Enhanced gastrointestinal motility with orally active ghrelin receptor agonists. J Pharmacol Exp Ther. 2009;329 (3) :1178-1186.

Shipping Conditions

Room temperature

Scientific Category

Reference Standards

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

8-Bromo-7-isobutyl-3-methyl-1H-purine-2,6 (3H,7H) -dione
YEA98054-01 5000 mg

8-Bromo-7-isobutyl-3-methyl-1H-purine-2,6 (3H,7H) -dione

Sign In for Pricing
View Details
8-Bromo-7-isobutyl-3-methyl-1H-purine-2,6 (3H,7H) -dione
YEA98054-02 10000 mg

8-Bromo-7-isobutyl-3-methyl-1H-purine-2,6 (3H,7H) -dione

Sign In for Pricing
View Details
CD32 (FCGR2A, CDw32, Fc-gamma RII-a, Fc-gamma-RIIa, FcRII-a, Low Affinity Immunoglobulin gamma Fc Region Receptor II-a, IgG Fc Receptor II-a, FCGR2A, FCG2, FCGR2A1, IGFR2) (MaxLight 750)
MBS6232011-01 0.1 mL

CD32 (FCGR2A, CDw32, Fc-gamma RII-a, Fc-gamma-RIIa, FcRII-a, Low Affinity Immunoglobulin gamma Fc Region Receptor II-a, IgG Fc Receptor II-a, FCGR2A, FCG2, FCGR2A1, IGFR2) (MaxLight 750)

Sign In for Pricing
View Details
CD32 (FCGR2A, CDw32, Fc-gamma RII-a, Fc-gamma-RIIa, FcRII-a, Low Affinity Immunoglobulin gamma Fc Region Receptor II-a, IgG Fc Receptor II-a, FCGR2A, FCG2, FCGR2A1, IGFR2) (MaxLight 750)
MBS6232011-02 5x 0.1 mL

CD32 (FCGR2A, CDw32, Fc-gamma RII-a, Fc-gamma-RIIa, FcRII-a, Low Affinity Immunoglobulin gamma Fc Region Receptor II-a, IgG Fc Receptor II-a, FCGR2A, FCG2, FCGR2A1, IGFR2) (MaxLight 750)

Sign In for Pricing
View Details
EXOSC10 (Exosome Component 10, Autoantigen PM/Scl 2, P100 Polymyositis-scleroderma Overlap Syndrome-associated Autoantigen, Polymyositis/Scleroderma Autoantigen 100kD, PM/Scl-100, Polymyositis/Scleroderma Autoantigen 2, PMSCL, PMSCL2, RRP6) (Biotin)
126506-Biotin 100 µL

EXOSC10 (Exosome Component 10, Autoantigen PM/Scl 2, P100 Polymyositis-scleroderma Overlap Syndrome-associated Autoantigen, Polymyositis/Scleroderma Autoantigen 100kD, PM/Scl-100, Polymyositis/Scleroderma Autoantigen 2, PMSCL, PMSCL2, RRP6) (Biotin)

Sign In for Pricing
View Details
Human Pancreas OptiTDS™ 2: Tissue Dissociation System
4-28316 1 Kit

Human Pancreas OptiTDS™ 2: Tissue Dissociation System

Sign In for Pricing
View Details